ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 15, 2016
Insider Transaction Report
Form 4
FRACTOR DAVID
Chief Financial Officer
Transactions
- Award
Common Stock
2016-03-11+35,000→ 70,000 total - Award
Stock Option (Right to Buy)
2016-03-11+100,000→ 100,000 totalExercise: $0.33Exp: 2026-03-10→ Common Stock (100,000 underlying)
Holdings
- 41,667(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of ImmunoCellular Therapeutics, Ltd. common stock. The restricted stock shall vest in full on the second anniversary of the grant date.
- [F2]Option shares shall vest in a series of 48 equal consecutive monthly installments commencing on April 11, 2016 until fully vested.